𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion

✍ Scribed by Maria J. Peñarrubia; Luz A. Silvestre; Joaquina Conde; Alberto Cantalapiedra; Luis J. Garcia Frade


Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
150 KB
Volume
33
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Efficacy of conventional cytogenetics an
✍ Ying S. Zou; Stephanie R. Fink; Kimberly J. Stockero; Sarah F. Paternoster; Step 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 267 KB

In clinical practice, whether FISH for EGR1 in interphase nuclei has similar efficacy to detect deletion 5q anomalies as conventional cytogenetic studies is unknown. We compared conventional cytogenetics and FISH for 145 patients with deletion 5q and detected this anomaly by both methods in 144. Nin

The CDCREL1 gene fused to MLL in de novo
✍ Ken Tatsumi; Tomohiko Taki; Masafumi Taniwaki; Hideo Nakamura; Jun Taguchi; Ying 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

We report on an adult patient with de novo acute myeloid leukemia (AML) with a t(11;22)(q23;q11.2) involving CDCREL1 and MLL genes. Reverse transcriptase (RT)-polymerase chain reaction (PCR) followed by direct sequencing analysis revealed the MLL-CDCREL1 fusion transcript in his leukemic cells. Anal

Glutathione S-transferases (GSTT1 and GS
✍ Zhijian Xiao; Lin Yang; Zefeng Xu; Yue Zhang; Liang Liu; Ling Nie; Lin Li; Jianx 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 224 KB

We investigated the prognostic significance of genetic polymorphism for glutathione S-transferase theta 1 (GSTT1) and glutathione S-transferase mu 1 (GSTM1) in 254 Chinese patients with de novo acute myeloid leukemia (AML) other than AML-M3. The early death rate after the initiation of chemotherapy

A scoring system to predict the risk of
✍ David Valcárcel; Pau Montesinos; Isabel Sánchez-Ortega; Salut Brunet; Jordi Este 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 2 views

## Abstract ## BACKGROUND: A prognostic index to predict induction death in adult patients receiving induction chemotherapy for de novo acute myeloid leukemia (AML) was developed. ## METHODS: The authors analyzed 570 patients (aged 16‐70 years) included in 2 multicenter trials of the CETLAM Grou